HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment

Meili Wang, Xiulan Zhao, Dongwang Zhu, Tieju Liu, Xiaohui Liang, Fang Liu, Yanhui Zhang, Xueyi Dong, Baocun SunJournal of Experimental & Clinical Cancer Research 2017 · DOI

TL;DR

This study reveals a critical pathway in liver cancer (HCC) where hypoxia (low oxygen) activates HIF-1α, which in turn boosts LOXL2 production. This LOXL2 surge drives cancer cell invasion and the formation of abnormal blood vessels (vasculogenic mimicry), ultimately worsening patient prognosis. Targeting LOXL2 presents a promising therapeutic strategy to combat HCC metastasis and progression.

What Problem Does This Paper Address?

Hepatocellular carcinoma (HCC) is a deadly cancer with increasing incidence and mortality. A key characteristic of many solid tumors, including HCC, is a hypoxic microenvironment. This low-oxygen state is known to fuel tumor growth, metastasis, and the development of new blood vessels (angiogenesis). Two processes, epithelial-mesenchymal transition (EMT) and vasculogenic mimicry (VM), are particularly implicated in cancer progression and metastasis. While the transcription factor HIF-1α is a master regulator of the cellular response to hypoxia, and LOXL2 (an enzyme involved in extracellular matrix remodeling) has been linked to cancer aggressiveness, the precise molecular link between HIF-1α, LOXL2, and the promotion of EMT and VM in HCC remained unclear. This paper aims to elucidate this pathway and its implications for HCC development and treatment.

Methods

The researchers employed a multi-pronged approach:

  • Immunohistochemistry: They analyzed human HCC tissue samples to assess the expression levels of HIF-1α and LOXL2 and correlated these with tumor grade, metastasis, and patient survival. They also used CD31/PAS double staining to identify and quantify vasculogenic mimicry (VM) channels.
  • Cell Culture and Manipulation: They used HCC cell lines (HepG2 and Bel7402) and manipulated gene expression. This included:
  • Knockdown: Using shRNA to reduce HIF-1α or LOXL2 levels.
  • Overexpression: Using lentiviral vectors to increase LOXL2 levels.
  • Hypoxia Mimicry: Treating cells with cobalt chloride (CoCl2) to simulate hypoxic conditions.
  • Functional Assays:
    • Transwell Assay: To measure cell invasion and migration.
  • Wound Healing Assay: To assess cell motility.
  • Three-dimensional Culture (Matrigel Assay): To evaluate the formation of tube-like structures indicative of VM.
  • Molecular Analysis:
    • Western Blotting: To quantify protein levels of HIF-1α, LOXL2, E-cadherin (an epithelial marker), and vimentin (a mesenchymal marker).
  • Quantitative Real-Time PCR (qRT-PCR): To measure mRNA expression levels of the same proteins.
  • Genome-wide Expression Profiling (Microarray): To identify differentially expressed genes in HCC cells with altered LOXL2 expression or under hypoxic conditions.
  • Bioinformatic Analysis: Including Gene Ontology (GO) analysis to understand the biological pathways affected by LOXL2 and hypoxia.
  • Statistical Analysis: Kaplan-Meier survival analysis, t-tests, and chi-squared tests were used to evaluate correlations and differences.

Datasets

The study utilized two main sources of data:

  • Human HCC Patient Samples: A cohort of 201 primary HCC tumor specimens were collected from patients who underwent hepatectomy. These samples were used for immunohistochemical analysis to correlate protein expression with clinical parameters and patient outcomes.
  • HCC Cell Lines: HepG2 and Bel7402 cell lines were used for in vitro experiments involving gene manipulation and functional assays.

Key Insights and Ideas

  • HIF-1α is the upstream driver: The study strongly suggests that hypoxia-induced HIF-1α is the primary initiator, directly promoting LOXL2 expression in HCC.
  • LOXL2 is the key mediator: LOXL2 acts as a crucial downstream effector, translating the HIF-1α signal into aggressive cellular behaviors like EMT and VM.
  • EMT and VM are interconnected: The findings highlight how HIF-1α and LOXL2 promote EMT, which in turn facilitates the formation of vasculogenic mimicry channels, creating an abnormal blood supply for the tumor.
  • Therapeutic target identified: The direct link between LOXL2 and aggressive phenotypes points to LOXL2 as a potential therapeutic target for inhibiting HCC metastasis and progression.
  • Prognostic significance: Both high HIF-1α and LOXL2 expression, as well as the presence of VM, were significantly correlated with poorer patient survival, underscoring their clinical relevance.

Key Results

  • Clinical Correlation: In 201 HCC samples, HIF-1α was highly expressed in 46.76% and LOXL2 in 50.75%. Both were positively correlated with tumor grade and VM, and associated with significantly poorer overall survival.
  • HIF-1α Induces LOXL2: Knockdown of HIF-1α reduced LOXL2 expression, while its overexpression increased LOXL2 levels in HCC cells, even under normoxic conditions.
  • LOXL2 Drives Aggression: Overexpression of LOXL2 in HCC cells promoted migration, invasion, and EMT (decreased E-cadherin, increased vimentin). Conversely, LOXL2 knockdown attenuated these effects.
  • VM Formation: HIF-1α and LOXL2 were shown to promote the formation of vasculogenic mimicry channels in vitro. Blocking LOXL2 significantly inhibited VM formation.
  • VE-cadherin Regulation: HIF-1α and LOXL2 influenced the expression of VE-cadherin, a marker of vascular mimicry.
  • Gene Expression Changes: Microarray analysis revealed significant gene expression alterations in response to LOXL2 overexpression and hypoxia, with several identified genes (e.g., CENPF, ATAD2) implicated in cell proliferation and tumor aggressiveness.

Limitations and Future Work

  • In Vitro vs. In Vivo: While the study provides strong in vitro evidence and clinical correlations, further in vivo studies are needed to fully validate the therapeutic potential of targeting LOXL2 in animal models.
  • Complexity of Tumor Microenvironment: The study focuses on the HIF-1α-LOXL2 axis. However, the tumor microenvironment is complex, involving numerous cell types and signaling pathways that could interact with this axis. Future research could explore these interactions.
  • Specific Gene Targets: While several genes were identified as differentially expressed, further functional studies are required to fully elucidate the roles of specific genes like CENPF and ATAD2 in LOXL2-mediated HCC progression.
  • Therapeutic Strategies: The paper highlights the potential of targeting LOXL2. Future work could focus on developing and testing specific LOXL2 inhibitors or other therapeutic strategies to suppress HCC metastasis and progression.

Summary updated

Abstract

HIF-1α plays an important role in the development of HCC by promoting HCC metastasis, EMT and VM through up-regulating LOXL2. This study highlights the potential therapeutic value of targeting LOXL2 for suppression of HCC metastasis and progression.
BibTeX
@article{wang2017hif,
  author = {Meili Wang and Xiulan Zhao and Dongwang Zhu and Tieju Liu and Xiaohui Liang and Fang Liu and Yanhui Zhang and Xueyi Dong and Baocun Sun},
  title = {{HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment}},
  journal = {Journal of Experimental \& Clinical Cancer Research},
  year = {2017},
  doi = {10.1186/s13046-017-0533-1},
}
Figure